July 27, 2021
Amid a wave of shipment restrictions on active vitamin D 3 analogs, the Japanese health ministry has issued a notification to prefectural authorities calling for prioritizing the supply of alfacalcidol to non-osteoporosis indications, where drug substitution is difficult. In the...read more